<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: European Facebook Usage Statistics</title>
	<atom:link href="http://deram.net/2010/06/11/european-facebook-usage-statistics/feed/" rel="self" type="application/rss+xml" />
	<link>http://deram.net/2010/06/11/european-facebook-usage-statistics/</link>
	<description>Pool, Marketing and much more!</description>
	<lastBuildDate>Sun, 20 Mar 2011 07:18:47 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.1.2</generator>
<xhtml:meta xmlns:xhtml="http://www.w3.org/1999/xhtml" name="robots" content="noindex" />
	<item>
		<title>By: European Facebook Usage Statistics - February 2011 &#124; Deram.net</title>
		<link>http://deram.net/2010/06/11/european-facebook-usage-statistics/comment-page-1/#comment-3165</link>
		<dc:creator>European Facebook Usage Statistics - February 2011 &#124; Deram.net</dc:creator>
		<pubDate>Wed, 09 Feb 2011 20:35:51 +0000</pubDate>
		<guid isPermaLink="false">http://deram.net/?p=116#comment-3165</guid>
		<description>[...] to my previous demograph from June 2010, some interesting evolutions can be [...]</description>
		<content:encoded><![CDATA[<p>[...] to my previous demograph from June 2010, some interesting evolutions can be [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Aura Rincones</title>
		<link>http://deram.net/2010/06/11/european-facebook-usage-statistics/comment-page-1/#comment-168</link>
		<dc:creator>Aura Rincones</dc:creator>
		<pubDate>Thu, 29 Jul 2010 17:19:33 +0000</pubDate>
		<guid isPermaLink="false">http://deram.net/?p=116#comment-168</guid>
		<description>Great site!!!</description>
		<content:encoded><![CDATA[<p>Great site!!!</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Letisha Vanderlee</title>
		<link>http://deram.net/2010/06/11/european-facebook-usage-statistics/comment-page-1/#comment-163</link>
		<dc:creator>Letisha Vanderlee</dc:creator>
		<pubDate>Thu, 29 Jul 2010 15:25:28 +0000</pubDate>
		<guid isPermaLink="false">http://deram.net/?p=116#comment-163</guid>
		<description>Great site!</description>
		<content:encoded><![CDATA[<p>Great site!</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Pharmg835</title>
		<link>http://deram.net/2010/06/11/european-facebook-usage-statistics/comment-page-1/#comment-151</link>
		<dc:creator>Pharmg835</dc:creator>
		<pubDate>Wed, 28 Jul 2010 04:11:42 +0000</pubDate>
		<guid isPermaLink="false">http://deram.net/?p=116#comment-151</guid>
		<description>Very nice site!</description>
		<content:encoded><![CDATA[<p>Very nice site!</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Pharmf960</title>
		<link>http://deram.net/2010/06/11/european-facebook-usage-statistics/comment-page-1/#comment-147</link>
		<dc:creator>Pharmf960</dc:creator>
		<pubDate>Wed, 28 Jul 2010 04:11:12 +0000</pubDate>
		<guid isPermaLink="false">http://deram.net/?p=116#comment-147</guid>
		<description>Hello! bfgdged interesting bfgdged site!</description>
		<content:encoded><![CDATA[<p>Hello! bfgdged interesting bfgdged site!</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Warner Abud</title>
		<link>http://deram.net/2010/06/11/european-facebook-usage-statistics/comment-page-1/#comment-129</link>
		<dc:creator>Warner Abud</dc:creator>
		<pubDate>Sun, 25 Jul 2010 07:21:28 +0000</pubDate>
		<guid isPermaLink="false">http://deram.net/?p=116#comment-129</guid>
		<description>Despite the fact that There&#039;s no doubt that your current write-up is on the appropriate course there are a number of factors that i tend not to go along with.</description>
		<content:encoded><![CDATA[<p>Despite the fact that There&#8217;s no doubt that your current write-up is on the appropriate course there are a number of factors that i tend not to go along with.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Hindi sms</title>
		<link>http://deram.net/2010/06/11/european-facebook-usage-statistics/comment-page-1/#comment-124</link>
		<dc:creator>Hindi sms</dc:creator>
		<pubDate>Sat, 24 Jul 2010 19:43:46 +0000</pubDate>
		<guid isPermaLink="false">http://deram.net/?p=116#comment-124</guid>
		<description>Don&#039;t you think you should have some more site like this ?</description>
		<content:encoded><![CDATA[<p>Don&#8217;t you think you should have some more site like this ?</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Shena Ready</title>
		<link>http://deram.net/2010/06/11/european-facebook-usage-statistics/comment-page-1/#comment-122</link>
		<dc:creator>Shena Ready</dc:creator>
		<pubDate>Sat, 24 Jul 2010 14:25:55 +0000</pubDate>
		<guid isPermaLink="false">http://deram.net/?p=116#comment-122</guid>
		<description>You make your own ideas nicely yet I still am not won over yet.</description>
		<content:encoded><![CDATA[<p>You make your own ideas nicely yet I still am not won over yet.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Toorflole</title>
		<link>http://deram.net/2010/06/11/european-facebook-usage-statistics/comment-page-1/#comment-112</link>
		<dc:creator>Toorflole</dc:creator>
		<pubDate>Thu, 22 Jul 2010 22:47:55 +0000</pubDate>
		<guid isPermaLink="false">http://deram.net/?p=116#comment-112</guid>
		<description>Generic drugs can bail someone out patients and insurance companies propertied costs. The chief estimate owing the to some degree sparse fee of generic medicines is that tournament increases aggregate producers when drugs no longer are protected about patents. Companies invite fewer costs in creating the generic upper, and are accordingly skilful to sustain profitability at a move expense to consumers. The costs of these generic drugs are so low that many developing countries can comfortably provide them. An eye to pattern, Thailand has imported millions of doses of a generic version of the blood-thinning analgesic Plavix (habituated to to assist prevent kindliness attacks), at a rate of 3 US cents per dose from India, the paramount producer of generic drugs.[2 - 
&lt;a href=&quot;http://caivn.org/users/videx-ec-1oh&quot; rel=&quot;nofollow&quot;&gt;Detrol&lt;/a&gt;&#124;
&lt;a href=&quot;http://caivn.org/users/arcoxia-1ej&quot; rel=&quot;nofollow&quot;&gt;Luvox&lt;/a&gt;&#124;
&lt;a href=&quot;http://caivn.org/users/trental-1th&quot; rel=&quot;nofollow&quot;&gt;Ilosone&lt;/a&gt;&#124;
&lt;a href=&quot;http://caivn.org/users/theolair-sr-1ad&quot; rel=&quot;nofollow&quot;&gt;Neggram&lt;/a&gt;&#124;
&lt;a href=&quot;http://caivn.org/users/theox-sr-1gh&quot; rel=&quot;nofollow&quot;&gt;Relenza&lt;/a&gt;&#124;
 
Generic manufacturers do not expose oneself to the get of drug ascertaining, and as an alternative are accomplished to reverse-engineer known drug compounds to allow them to turn out bioequivalent versions. Generic manufacturers also do not hold out the burden of proving the safe keeping and efficacy of the drugs during clinical trials, since these trials deliver already been conducted nearby the mark fame company. (Realize the Approval and &lt;a href=&quot;http://caivn.org/users/lopressor-1mj&quot; rel=&quot;nofollow&quot;&gt;Albenza&lt;/a&gt;&#124;
  apportion, downstairs, in search more knowledge about the countenance process.) It has been estimated that the normally cost to brand-name drug companies of discovering and testing
&lt;a href=&quot;http://caivn.org/users/oxsoralen-1fb&quot; rel=&quot;nofollow&quot;&gt;Cataflam-Sr&lt;/a&gt;&#124;
&lt;a href=&quot;http://caivn.org/users/crixivan-1tz&quot; rel=&quot;nofollow&quot;&gt;Biaxin&lt;/a&gt;&#124;
&lt;a href=&quot;http://caivn.org/users/famvir-1aw&quot; rel=&quot;nofollow&quot;&gt;Theo-24-Tr&lt;/a&gt;&#124;
&lt;a href=&quot;http://caivn.org/users/videx-1vp&quot; rel=&quot;nofollow&quot;&gt;Levitra-Brand&lt;/a&gt;&#124;
&lt;a href=&quot;http://caivn.org/users/diltiazem-1qk&quot; rel=&quot;nofollow&quot;&gt;Detrol-La&lt;/a&gt;&#124;
 
 a unusual innovative drug (with a late-model chemical entity) may be as much as $800 million.[3 -  &lt;a href=&quot;http://caivn.org/users/arcoxia-1ej&quot; rel=&quot;nofollow&quot;&gt;Cialis-Brand&lt;/a&gt;&#124;
  that &lt;a href=&quot;http://caivn.org/users/paxil-cr-1tx&quot; rel=&quot;nofollow&quot;&gt;Sorbitrate-Tr&lt;/a&gt;&#124;
  is disputed in Merril Goozner&#039;s ticket the $800 Million Dollar Pill. Goozner estimates that the constant get of bringing a contemporary drug to call is closer to $100–$200 million [4 - 
Generic tranquillizer companies may also make the service perquisites of the untimely marketing efforts of the brand-name psychedelic group, including media advertising, presentations close to panacea representatives, and deployment of unceremonious samples. Many of the drugs introduced nigh generic manufacturers contain already been on the peddle looking for a decade or more, and may already be well-known to patients and providers (although commonly under their branded name).
&lt;a href=&quot;http://caivn.org/users/ceftin-1ak&quot; rel=&quot;nofollow&quot;&gt;Dexone&lt;/a&gt;&#124;
  as sustained as a hallucinogenic copyright lasts, a brand name name attendance enjoys a spell of “market exclusivity” or monopoly, in which the comrades is masterly to set the expense of the medicate at a uniform which maximizes profitability. This payment time again greatly exceeds the preparation costs of the narcotic, which can enable the pharmaceutical retinue to contrive a notable profit on their investment in fact-finding and progress, accordingly enabling them to stock the investigating and event of untrodden medicines which most generic companies cannot afford to do. The advantage of generic drugs to consumers comes in the introduction of contest, which prevents any distinct presence from dictating the inclusive store value of the drug. Competition is also seen between generic and name-brand drugs with similar therapeutic uses when physicians or healthfulness plans take policies of preferentially prescribing generic drugs as in not harmonious with therapy. With multiple firms producing the generic manifestation of a stimulant the profit-maximizing price generally falls to the ongoing charge of producing the pharmaceutical, which is usually much lower than the monopoly value
&lt;a href=&quot;http://caivn.org/users/femcare-1ep&quot; rel=&quot;nofollow&quot;&gt;Lasix&lt;/a&gt;&#124;
&lt;a href=&quot;http://caivn.org/users/theox-sr-1gh&quot; rel=&quot;nofollow&quot;&gt;Amoxil&lt;/a&gt;&#124;
&lt;a href=&quot;http://caivn.org/users/vigora-1br&quot; rel=&quot;nofollow&quot;&gt;Lariam&lt;/a&gt;&#124;
&lt;a href=&quot;http://caivn.org/users/keflex-1yd&quot; rel=&quot;nofollow&quot;&gt;Urso&lt;/a&gt;&#124;
&lt;a href=&quot;http://caivn.org/users/slo-phyllin-tr-1ly&quot; rel=&quot;nofollow&quot;&gt;Claritin&lt;/a&gt;&#124;</description>
		<content:encoded><![CDATA[<p>Generic drugs can bail someone out patients and insurance companies propertied costs. The chief estimate owing the to some degree sparse fee of generic medicines is that tournament increases aggregate producers when drugs no longer are protected about patents. Companies invite fewer costs in creating the generic upper, and are accordingly skilful to sustain profitability at a move expense to consumers. The costs of these generic drugs are so low that many developing countries can comfortably provide them. An eye to pattern, Thailand has imported millions of doses of a generic version of the blood-thinning analgesic Plavix (habituated to to assist prevent kindliness attacks), at a rate of 3 US cents per dose from India, the paramount producer of generic drugs.[2 &#8211;<br />
<a href="http://caivn.org/users/videx-ec-1oh" rel="nofollow">Detrol</a>|<br />
<a href="http://caivn.org/users/arcoxia-1ej" rel="nofollow">Luvox</a>|<br />
<a href="http://caivn.org/users/trental-1th" rel="nofollow">Ilosone</a>|<br />
<a href="http://caivn.org/users/theolair-sr-1ad" rel="nofollow">Neggram</a>|<br />
<a href="http://caivn.org/users/theox-sr-1gh" rel="nofollow">Relenza</a>|</p>
<p>Generic manufacturers do not expose oneself to the get of drug ascertaining, and as an alternative are accomplished to reverse-engineer known drug compounds to allow them to turn out bioequivalent versions. Generic manufacturers also do not hold out the burden of proving the safe keeping and efficacy of the drugs during clinical trials, since these trials deliver already been conducted nearby the mark fame company. (Realize the Approval and <a href="http://caivn.org/users/lopressor-1mj" rel="nofollow">Albenza</a>|<br />
  apportion, downstairs, in search more knowledge about the countenance process.) It has been estimated that the normally cost to brand-name drug companies of discovering and testing<br />
<a href="http://caivn.org/users/oxsoralen-1fb" rel="nofollow">Cataflam-Sr</a>|<br />
<a href="http://caivn.org/users/crixivan-1tz" rel="nofollow">Biaxin</a>|<br />
<a href="http://caivn.org/users/famvir-1aw" rel="nofollow">Theo-24-Tr</a>|<br />
<a href="http://caivn.org/users/videx-1vp" rel="nofollow">Levitra-Brand</a>|<br />
<a href="http://caivn.org/users/diltiazem-1qk" rel="nofollow">Detrol-La</a>|</p>
<p> a unusual innovative drug (with a late-model chemical entity) may be as much as $800 million.[3 &#8211;  <a href="http://caivn.org/users/arcoxia-1ej" rel="nofollow">Cialis-Brand</a>|<br />
  that <a href="http://caivn.org/users/paxil-cr-1tx" rel="nofollow">Sorbitrate-Tr</a>|<br />
  is disputed in Merril Goozner&#8217;s ticket the $800 Million Dollar Pill. Goozner estimates that the constant get of bringing a contemporary drug to call is closer to $100–$200 million [4 &#8211;<br />
Generic tranquillizer companies may also make the service perquisites of the untimely marketing efforts of the brand-name psychedelic group, including media advertising, presentations close to panacea representatives, and deployment of unceremonious samples. Many of the drugs introduced nigh generic manufacturers contain already been on the peddle looking for a decade or more, and may already be well-known to patients and providers (although commonly under their branded name).<br />
<a href="http://caivn.org/users/ceftin-1ak" rel="nofollow">Dexone</a>|<br />
  as sustained as a hallucinogenic copyright lasts, a brand name name attendance enjoys a spell of “market exclusivity” or monopoly, in which the comrades is masterly to set the expense of the medicate at a uniform which maximizes profitability. This payment time again greatly exceeds the preparation costs of the narcotic, which can enable the pharmaceutical retinue to contrive a notable profit on their investment in fact-finding and progress, accordingly enabling them to stock the investigating and event of untrodden medicines which most generic companies cannot afford to do. The advantage of generic drugs to consumers comes in the introduction of contest, which prevents any distinct presence from dictating the inclusive store value of the drug. Competition is also seen between generic and name-brand drugs with similar therapeutic uses when physicians or healthfulness plans take policies of preferentially prescribing generic drugs as in not harmonious with therapy. With multiple firms producing the generic manifestation of a stimulant the profit-maximizing price generally falls to the ongoing charge of producing the pharmaceutical, which is usually much lower than the monopoly value<br />
<a href="http://caivn.org/users/femcare-1ep" rel="nofollow">Lasix</a>|<br />
<a href="http://caivn.org/users/theox-sr-1gh" rel="nofollow">Amoxil</a>|<br />
<a href="http://caivn.org/users/vigora-1br" rel="nofollow">Lariam</a>|<br />
<a href="http://caivn.org/users/keflex-1yd" rel="nofollow">Urso</a>|<br />
<a href="http://caivn.org/users/slo-phyllin-tr-1ly" rel="nofollow">Claritin</a>|</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: LYNN</title>
		<link>http://deram.net/2010/06/11/european-facebook-usage-statistics/comment-page-1/#comment-107</link>
		<dc:creator>LYNN</dc:creator>
		<pubDate>Thu, 22 Jul 2010 06:42:22 +0000</pubDate>
		<guid isPermaLink="false">http://deram.net/?p=116#comment-107</guid>
		<description>&lt;strong&gt;&lt;blockquote&gt;&lt;a href=&quot;http://medicamentspot.com/&quot; rel=&quot;nofollow&quot;&gt;MedicamentSpot.com. Canadian Health&amp;Care.No prescription online pharmacy.Special Internet Prices.Best quality drugs. Low price pills. Order pills online&lt;/a&gt;...&lt;/strong&gt;

Buy:Nexium.Valtrex.Actos.Synthroid.Lumigan.Retin-A.Accutane.Petcam (Metacam) Oral Suspension.Zyban.Mega Hoodia.Prevacid.100% Pure Okinawan Coral Calcium.Prednisolone.Human Growth Hormone.Zovirax.Arimidex....</description>
		<content:encoded><![CDATA[<p><strong><br />
<blockquote><a href="http://medicamentspot.com/" rel="nofollow">MedicamentSpot.com. Canadian Health&amp;Care.No prescription online pharmacy.Special Internet Prices.Best quality drugs. Low price pills. Order pills online</a>&#8230;</p></blockquote>
<p></strong></p>
<p>Buy:Nexium.Valtrex.Actos.Synthroid.Lumigan.Retin-A.Accutane.Petcam (Metacam) Oral Suspension.Zyban.Mega Hoodia.Prevacid.100% Pure Okinawan Coral Calcium.Prednisolone.Human Growth Hormone.Zovirax.Arimidex&#8230;.</p>
]]></content:encoded>
	</item>
</channel>
</rss>

